Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alkaline phosphatase, tissue-nonspecific isozyme (TNAP) is an enzyme encoded by the ALPL gene. It catalyzes the dephosphorylation of phosphate esters such as inorganic pyrophosphate (PPi), pyridoxal 5'-phosphate (PLP), and phosphoethanolamine (PEA). It plays a critical role in skeletal mineralization and vitamin B6 metabolism. Mutations cause hypophosphatasia with variable severity, affecting bone and tooth mineralization.
Inhibition of TNAP would theoretically prevent dephosphorylation of PPi, PLP and PEA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alkaline Phosphatase, Tissue-Nonspecific Isozyme (TNAP).